Milestone Scientific Reports a 61% Increase in Revenue for Q1 2021
May 17, 2021 07:30 ET
|
Milestone Scientific, Inc.
Achieves 32% sequential increase in revenue for Q1 2021 versus Q4 2020 Reports approximately $17 million of cash and cash equivalents as of March 31, 2021 ROSELAND, N.J., May 17, 2021 (GLOBE...
Milestone Scientific Announces Promotion of Arjan Haverhals to CEO
May 13, 2021 08:00 ET
|
Milestone Scientific, Inc.
Finance veteran Scott Kahn appointed CFO Leonard Osser elected Vice Chairman of the Board of Directors ROSELAND, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a...
Milestone Scientific Schedules First Quarter 2021 Business Update Conference Call
May 12, 2021 10:54 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and...
Milestone Scientific Reports Preliminary Sales Results for Q1 2021; Revenue Increases 61% Over the Same Period Last Year
May 03, 2021 08:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
Milestone Scientific Provides 2020 Year-End Business Update; Reports a 78% Sequential Increase in Revenue for Q4 2020 Versus Q3 2020
April 01, 2021 07:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
Milestone Scientific Schedules 2020 Year-End Business Update Conference Call
March 30, 2021 10:28 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and...
Milestone Scientific Receives Notice of Allowance for European Patent Related to Combination of Nerve Stimulation and DPS Dynamic Pressure Sensing Technology® to Optimize Needle Tip Location in Ultrasound-Guided PNB Procedures
March 10, 2021 15:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., March 10, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and...
Milestone Scientific Inc. Commences Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized Medical University of South Carolina
March 02, 2021 09:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and...
Milestone Scientific Inc. Announces Breakthrough CompuPulse System and Receives Notice of Allowance for U.S. Patent
February 24, 2021 15:15 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and...
Milestone Scientific Inc. Commences Sales of CompuFlo® Epidural Instruments and Disposables to University Hospital of Würzburg in Germany
February 23, 2021 09:30 ET
|
Milestone Scientific, Inc.
ROSELAND, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and...